Induction of WNT inhibitory factor 1 expression by müllerian inhibiting substance/antimullerian hormone in the müllerian duct mesenchyme is linked to müllerian duct regression

Developmental Biology

Volumn 386, Issue 1, 2014, Pages 227-236

  Park, Joo Hyun ^a,c,d   Tanaka, Yoshihiro ^a,c   Arango, Nelson A ^a,c,e   Zhang, Lihua ^a   Benedict, L Andrew ^a,c   Roh, Mi In ^b,c   Donahoe, Patricia K ^a,c   Teixeira, Jose M ^a,c,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Yonsei University College of Medicine   (South Korea)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

AntiM llerian hormone; Reproductive tract development; WNT signaling

Indexed keywords

BETA CATENIN; MUELLERIAN INHIBITING FACTOR; SMALL INTERFERING RNA; WNT1 PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENZYME RELEASE; EPITHELIUM CELL; FEMALE; GENE; GENE SILENCING; IN SITU HYBRIDIZATION; MALE; MESENCHYME CELL; MICROARRAY ANALYSIS; MISR2 GENE; MOUSE; MUELLERIAN DUCT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SERTOLI CELL; SEXUAL DEVELOPMENT; TESTIS; UROGENITAL SYSTEM; WIF1 GENE; ANIMAL EXPERIMENT; EPITHELIUM; IMMUNOFLUORESCENCE; KNOCKOUT MOUSE; MESENCHYME; NICK END LABELING; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

MAMMALIA;

ANTIMÜLLERIAN HORMONE; REPRODUCTIVE TRACT DEVELOPMENT; WNT SIGNALING;

ANIMALS; ANTI-MULLERIAN HORMONE; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MESODERM; MICE; MICE, INBRED C57BL; MULLERIAN DUCTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SERTOLI CELLS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84892483507     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2013.12.015     Document Type: Article

References (60)

1. Allard S., Adin P., Gouedard L., di Clemente N., Josso N., Orgebin-Crist M.C., Picard J.Y., Xavier F. Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin. Development 2000, 127(15):3349-3360.
2. Arango N.A., Kobayashi A., Wang Y., Jamin S.P., Lee H.H., Orvis G.D., Behringer R.R. A mesenchymal perspective of Mullerian duct differentiation and regression in Amhr2-lacZ mice. Mol. Reprod. Dev. 2008, 75(7):1154-1162.
3. Arango N.A., Szotek P.P., Manganaro T.F., Oliva E., Donahoe P.K., Teixeira J. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol. 2005, 288(1):276-283.
4. Baarends W.M., van Helmond M.J., Post M., van der Schoot P.J., Hoogerbrugge J.W., de Winter J.P., Uilenbroek J.T., Karels B., Wilming L.G., Meijers J.H., et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 1994, 120(1):189-197.
5. Behringer R.R., Finegold M.J., Cate R.L. Mullerian-inhibiting substance function during mammalian sexual development. Cell 1994, 79(3):415-425.
6. Belville C., Van Vlijmen H., Ehrenfels C., Pepinsky B., Rezaie A.R., Picard J.Y., Josso N., di Clemente N., Cate R.L. Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol. Endocrinol. 2004, 18(3):708-721.
7. Catlin E.A., Tonnu V.C., Ebb R.G., Pacheco B.A., Manganaro T.F., Ezzell R.M., Donahoe P.K., Teixeira J. Mullerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung. Endocrinology 1997, 138(2):790-796.
8. Clarke T.R., Hoshiya Y., Yi S.E., Liu X., Lyons K.M., Donahoe P.K. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol. Endocrinol. 2001, 15(6):946-959.
9. Daikoku T., Cha J., Sun X., Tranguch S., Xie H., Fujita T., Hirota Y., Lydon J., DeMayo F., Maxson R., Dey S.K. Conditional deletion of Msx homeobox genes in the uterus inhibits blastocyst implantation by altering uterine receptivity. Dev. Cell 2011, 21(6):1014-1025.
10. di Clemente N., Wilson C., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.Y., Vigier B., Josso N., Cate R. Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol. Endocrinol. 1994, 8(8):1006-1020.
11. Fujino A., Arango N.A., Zhan Y., Manganaro T.F., Li X., MacLaughlin D.T., Donahoe P.K. Cell migration and activated PI3K/AKT-directed elongation in the developing rat Mullerian duct. Dev. Biol. 2009, 325(2):351-362.
12. Gouedard L., Chen Y.G., Thevenet L., Racine C., Borie S., Lamarre I., Josso N., Massague J., di Clemente N. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor. J. Biol. Chem. 2000, 275(36):27973-27978.
13. Guioli S., Sekido R., Lovell-Badge R. The origin of the Mullerian duct in chick and mouse. Dev. Biol. 2007, 302(2):389-398.
14. Ha Y., Tsukada A., Saito N., Zadworny D., Shimada K. Identification of differentially expressed genes involved in the regression and development of the chicken Mullerian duct. Int. J. Dev. Biol. 2008, 52(8):1135-1141.
15. Hayashi A., Donahoe P.K., Budzik G.P., Trelstad R.L. Periductal and matrix glycosaminoglycans in rat Mullerian duct development and regression. Dev. Biol. 1982, 92(1):16-26.
16. He X., Saint-Jeannet J.P., Wang Y., Nathans J., Dawid I., Varmus H. A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 1997, 275(5306):1652-1654.
17. Hsieh J.C., Kodjabachian L., Rebbert M.L., Rattner A., Smallwood P.M., Samos C.H., Nusse R., Dawid I.B., Nathans J. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999, 398(6726):431-436.
18. Jamin S.P., Arango N.A., Mishina Y., Hanks M.C., Behringer R.R. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat. Genet. 2002, 32(3):408-410.
19. Josso N., Belville C., di Clemente N., Picard J.Y. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum. Reprod. Update 2005, 11(4):351-356.
20. Josso N., Clemente N. Transduction pathway of anti-Mullerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol. Metab. 2003, 14(2):91-97.
21. Kansara M., Tsang M., Kodjabachian L., Sims N.A., Trivett M.K., Ehrich M., Dobrovic A., Slavin J., Choong P.F., Simmons P.J., Dawid I.B., Thomas D.M. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J. Clin. Invest. 2009, 119(4):837-851.
22. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 2003, 116(Pt 13):2627-2634.
23. Keil K.P., Mehta V., Branam A.M., Abler L.L., Buresh-Stiemke R.A., Joshi P.S., Schmitz C.T., Marker P.C., Vezina C.M. Wnt inhibitory factor 1 (Wif1) is regulated by androgens and enhances androgen-dependent prostate development. Endocrinology 2012, 153(12):6091-6103.
24. Kobayashi A., Behringer R.R. Developmental genetics of the female reproductive tract in mammals. Nat. Rev. Genet. 2003, 4(12):969-980.
25. Kobayashi A., Stewart C.A., Wang Y., Fujioka K., Thomas N.C., Jamin S.P., Behringer R.R. beta-Catenin is essential for Mullerian duct regression during male sexual differentiation. Development 2011, 138(10):1967-1975.
26. Kraus P., Lufkin T. Dlx homeobox gene control of mammalian limb and craniofacial development. Am. J. Med. Genet. A 2006, 140(13):1366-1374.
27. Loscertales M., Mikels A.J., Hu J.K., Donahoe P.K., Roberts D.J. Chick pulmonary Wnt5a directs airway and vascular tubulogenesis. Development 2008, 135(7):1365-1376.
28. Mericskay M., Kitajewski J., Sassoon D. Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 2004, 131(9):2061-2072.
29. Mikels A.J., Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006, 4(4):e115.
30. Mikels A.J., Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 2006, 25(57):7461-7468.
31. Miller C., Sassoon D.A. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 1998, 125(16):3201-3211.
32. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 1996, 10(20):2577-2587.
33. Mucenski M.L., Nation J.M., Thitoff A.R., Besnard V., Xu Y., Wert S.E., Harada N., Taketo M.M., Stahlman M.T., Whitsett J.A. Beta-catenin regulates differentiation of respiratory epithelial cells in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289(6):L971-L979.
34. Mucenski M.L., Wert S.E., Nation J.M., Loudy D.E., Huelsken J., Birchmeier W., Morrisey E.E., Whitsett J.A. beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis. J. Biol. Chem. 2003, 278(41):40231-40238.
35. Nef S., Parada L.F. Cryptorchidism in mice mutant for Insl3. Nat. Genet. 1999, 22(3):295-299.
36. Okubo T., Hogan B.L. Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J. Biol. 2004, 3(3):11.
37. Orvis G.D., Behringer R.R. Cellular mechanisms of Mullerian duct formation in the mouse. Dev. Biol. 2007, 306(2):493-504.
38. Orvis G.D., Jamin S.P., Kwan K.M., Mishina Y., Kaartinen V.M., Huang S., Roberts A.B., Umans L., Huylebroeck D., Zwijsen A., Wang D., Martin J.F., Behringer R.R. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse. Biol. Reprod. 2008, 78(6):994-1001.
39. Parr B.A., McMahon A.P. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998, 395(6703):707-710.
40. Picon R. [Action of the fetal testis on the development in vitro of the Mullerian ducts in the rat]. Arch. Anat. Microsc. Morphol. Exp. 1969, 58(1):1-19.
41. Ragin R.C., Donahoe P.K., Kenneally M.K., Ahmad M.F., MacLaughlin D.T. Human mullerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects. Protein Expression Purif. 1992, 3(3):236-245.
42. Ramachandran I., Thavathiru E., Ramalingam S., Natarajan G., Mills W.K., Benbrook D.M., Zuna R., Lightfoot S., Reis A., Anant S., Queimado L. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 2012, 31(22):2725-2737.
43. Roberts L.M., Visser J.A., Ingraham H.A. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development 2002, 129(6):1487-1496.
44. Satokata I., Ma L., Ohshima H., Bei M., Woo I., Nishizawa K., Maeda T., Takano Y., Uchiyama M., Heaney S., Peters H., Tang Z., Maxson R., Maas R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 2000, 24(4):391-395.
45. Schaniel C., Sirabella D., Qiu J., Niu X., Lemischka I.R., Moore K.A. Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells. Blood 2011, 118(9):2420-2429.
46. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 2001, 1:4.
47. Swain A., Narvaez V., Burgoyne P., Camerino G., Lovell-Badge R. Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998, 391(6669):761-767.
48. Tanwar P.S., Lee H.J., Zhang L., Zukerberg L.R., Taketo M.M., Rueda B.R., Teixeira J.M. Constitutive activation of beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice. Biol. Reprod. 2009, 81(3):545-552.
49. Tanwar P.S., Zhang L., Tanaka Y., Taketo M.M., Donahoe P.K., Teixeira J.M. Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme. Proc. Nat. Acad. Sci. U.S.A. 2010, 107(37):16142-16147.
50. Teixeira J., He W.W., Shah P.C., Morikawa N., Lee M.M., Catlin E.A., Hudson P.L., Wing J., Maclaughlin D.T., Donahoe P.K. Developmental expression of a candidate mullerian inhibiting substance type II receptor. Endocrinology 1996, 137(1):160-165.
51. Teixeira J., Maheswaran S., Donahoe P.K. Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr. Rev. 2001, 22(5):657-674.
52. Trelstad R.L., Hayashi A., Hayashi K., Donahoe P.K. The epithelial-mesenchymal interface of the male rate Mullerian duct: loss of basement membrane integrity and ductal regression. Dev. Biol. 1982, 92(1):27-40.
53. Tsuji M., Shima H., Yonemura C.Y., Brody J., Donahoe P.K., Cunha G.R. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat. Endocrinology 1992, 131(3):1481-1488.
54. van Amerongen R., Mikels A., Nusse R. Alternative Wnt signaling is initiated by distinct receptors. Sci Signal. 2008, 1(35). p. re9.
55. van Amerongen R., Fuerer C., Mizutani M., Nusse R. Wnt5a can both activate and repress Wnt/beta-catenin signaling during mouse embryonic development. Dev. Biol. 2012, 369(1):101-114.
56. Visser J.A., Olaso R., Verhoef-Post M., Kramer P., Themmen A.P., Ingraham H.A. The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol. Endocrinol. 2001, 15(6):936-945.
57. Xu B., Chen C., Chen H., Zheng S.G., Bringas P., Xu M., Zhou X., Chen D., Umans L., Zwijsen A., Shi W. Smad1 and its target gene Wif1 coordinate BMP and Wnt signaling activities to regulate fetal lung development. Development 2011, 138(5):925-935.
58. Yin Y., Lin C., Ma L. MSX2 promotes vaginal epithelial differentiation and wolffian duct regression and dampens the vaginal response to diethylstilbestrol. Mol. Endocrinol. 2006, 20(7):1535-1546.
59. Zhan Y., Fujino A., MacLaughlin D.T., Manganaro T.F., Szotek P.P., Arango N.A., Teixeira J., Donahoe P.K. Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 2006, 133(12):2359-2369.
60. Zimmermann S., Steding G., Emmen J.M., Brinkmann A.O., Nayernia K., Holstein A.F., Engel W., Adham I.M. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol. Endocrinol. 1999, 13(5):681-691.